AstraZeneca Income After Taxes 2010-2024 | AZN

AstraZeneca income after taxes for the twelve months ending June 30, 2024 was $6.445B, a 4.47% increase year-over-year.

  • AstraZeneca annual income after taxes for 2023 was $5.961B, a 81.02% increase from 2022.
  • AstraZeneca annual income after taxes for 2022 was $3.293B, a 2763.48% increase from 2021.
  • AstraZeneca annual income after taxes for 2021 was $0.115B, a 96.34% decline from 2020.

AstraZeneca Income After Taxes 2010-2024 | AZN

  • AstraZeneca annual income after taxes for 2023 was $5.961B, a 81.02% increase from 2022.
  • AstraZeneca annual income after taxes for 2022 was $3.293B, a 2763.48% increase from 2021.
  • AstraZeneca annual income after taxes for 2021 was $0.115B, a 96.34% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
Novartis AG (NVS)$236.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B